{"id":"W1712386042","doi":"10.1158/1538-7445.sabcs14-s3-02","title":"Abstract S3-02: NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer","year":2015,"lang":"en","type":"article","venue":"Cancer Research","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre hospitalier universitaire de Québec; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Epirubicin; Medicine; Internal medicine; Breast cancer; Clinical endpoint; Cyclophosphamide; Placebo; Fluorouracil; Oncology; Adverse effect; Randomized controlled trial; Cancer; Chemotherapy; Gastroenterology; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00149173,0.002089395,0.002545387,0.0005419874,0.0004722398,0.0009133749,0.001009272,0.002150472,0.01325437],"category_scores_gemma":[0.001475981,0.0007525792,0.001434976,0.0005735671,0.00147262,0.0007852374,0.0004015873,0.003155519,0.001683031],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007909887,"about_ca_system_score_gemma":0.002016447,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001618781,"about_ca_topic_score_gemma":0.003293939,"domain_scores_codex":[0.9994119,0.0003343936,0.00003771235,0.00008199405,0.00004057002,0.00009328575],"domain_scores_gemma":[0.9992462,0.0001544973,0.0001171779,0.00003708182,0.00004101359,0.0004040645],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9841337,0.004517334,0.0002809943,0.0003639369,0.000244202,0.0000370645,0.00002813578,0.0002446516,0.002925408,0.00009353325,0.000784537,0.006346495],"study_design_scores_gemma":[0.9656474,0.0329162,0.0004628198,0.000012324,0.000105043,0.00001471743,0.000007807615,0.000160331,0.0002505283,0.00006617601,0.0003507435,0.000005953285],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9691881,0.003710509,0.0009495303,0.001584614,0.0007822379,0.01659893,0.003908315,0.0003330407,0.002944813],"genre_scores_gemma":[0.9646936,0.002508073,0.003143481,0.001972884,0.0005204619,0.01495614,0.002538501,0.00004588317,0.009620911],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01325437,"threshold_uncertainty_score":0.04434031,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03247068989714694,"score_gpt":0.3438482803364555,"score_spread":0.3113775904393085,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}